In advance of the ending of the COVID-19 public health emergency on May 11, the FDA will end some of the 72 pandemic-related guidance policies and keep some in place for an additional 180 days after the PHE ends, according to a notice in the March 13 F…
President Joe Biden on March 20 signed a bill into law to declassify information about the pandemic’s origins.
In-person mental health care is hard to arrange in rural nursing homes, so video chats with faraway professionals are filling the gap.
Researchers have discovered new data around the origins of the COVID-19 pandemic, and WHO is calling on China to be transparent about their research and data, Science reported March 17.
A U.S. District Court case is being widely followed because the judge’s decision could overturn the FDA’s approval of mifepristone two decades ago. With abortion rights polling well even in red states, anti-abortion activists are increasingly turning to the courts to achieve their aims.
As part of an expansion to its wastewater surveillance program, the Chicago Department of Public Health will begin testing for poliovirus, according to a March 17 report from NBC NBC 5 Chicago.
Babesiosis, a tick-borne illness, has become endemic in three more states, NBC News reported March 16.
As part of an updated tracking system for SARS-CoV-2 variants, the World Health Organization will move to evaluate omicron sublineages independently to better identify potential new threats.
Researchers have found new genetic data that links SARS-CoV-2, the virus that causes COVID-19, with raccoon dogs sold at a market in Wuhan, China, The Atlantic reported March 16.
Any day now a conservative federal judge in Texas could upend the national abortion debate by requiring the FDA to rescind its approval of mifepristone, a drug approved in the U.S. more than 20 years ago that is now used in more than half of abortions nationwide. Meanwhile, a controversial study on masks gets a clarification, although it may be too late to change the public impression of what it found. Alice Miranda Ollstein of Politico, Jessie Hellmann of CQ Roll Call, and Sarah Karlin-Smith of the Pink Sheet join KHN chief Washington correspondent Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
